Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial - Patil, V; Noronha, V; Dhumal, S B (Lancet Glob Health, 2020)